Item 3 to Schedule 13D is hereby amended to include the following: On March 26, 2025, the Issuer and funds managed by the Reporting Persons agreed to extend the maturity date of the Notes from January 1, 2026 to May 1, 2027 (the "2025 Extension"). In addition, the Notes were amended to, among other things, provide for the payment of interest commencing January 1, 2026 at a rate of 10% per annum, with the interest payable, at the election of the Issuer, in the form of cash or Common Stock. As consideration for the 2025 Extension, the Issuer agreed (x) to amend the warrants issued on June 22, 2022 to purchase an aggregate of 531,250 shares of Common Stock at an exercise price of $5.20 per share (the "2022 Warrants") to (i) reduce the exercise price to $2.00 per share and (ii) extend the expiration date from June 22, 2027 to December 31, 2029 and (y) that the resale registration rights set forth in the 2022 Registration Rights Agreement would be applicable to the Shares issuable upon conversion of the 2022 Warrants, as amended.

Exhibit 99.1: Introductory Statement